Second Curve’s Tom Brown is Bullish on JP Morgan (JPM)

Second Curve’s Tom Brown, CEO of Second Curve Capital and a Bloomberg TV contributing editor, spoke with Betty Liu and Jon Erlichman on the phone. He discussed JP Morgan Chase’s (JPM) fourth quarter results. He said he expects JP Morgan to increase dividend payments during the second quarter. “There will be stock buybacks down the road in addition to a nice dividend increase,” Brown said.

JPMorgan Chase & Co (NYSE:JPM)

Thomas Brown was clearly bullish on JP Morgan. “They not only report better than expected results but the accounting is very conservative. So they are positioning themselves well for the future,” added Brown.

Tom Brown’s Second Curve invests exclusively in financial companies, mostly in small to midcap names. Here are his top 10 holdings in his latest 13F (in alphabetical order):

1. Altisource Portfolio Solutions (ASPS): Altisource lost nearly 7% since this filing, underperforming the market by a large margin. Altisource insiders were selling as the stock price went from $31 to $27 in November.

2. Banner Corp (BANR): Banner Corp gained 4.7% since the end of September. The stock declined by more than 25% until mid December and took off after that. Steven W. Rust, Executive VP of Banner, made a small but very profitable purchase as the stock hit the bottom on December 16th. The stock returned 39% in less than a month after the transaction.

3. Cobiz Financial (COBZ): Cobiz increased by 11.5% since September 30th. Like other financial stocks, Cobiz declined from $5.55 at the end of September to as low as $4.71 on October 29th. Cobiz’s Chief Credit Officer, Robert Ostertag, stepped in on October 29th as he saw Cobiz’s stock price dipping at $4.71 and purchased 1,500 shares at $4.76. Currently Cobiz trades at $6.19 and Ostertag’s return is almost 30%. Insiders know when it’s a good time to buy.

4. Compucredit Corp (CCRT): Compucredit returned 47% since the end of September. As some insiders were selling Compucredit above $6.50, Tom Brown’s Second Curve was buying it below $7. Brown is also an insider of this company, owning more than 10% of outstanding shares.

5. Ocwen Financial (OCN): Ocwen increased by only 4% since September. William C. Erbey, chairman of Ocwen and also a director at Altisource, was selling both OCN and ASPS stocks when they were down. Ronald M Faris, president and CEO of Ocwen, is a much smarter insider. In May 2009, he sold Ocwen stock at $12.75 per share. In August 2010, he bought back 10,000 shares at $8.78. He knew when to sell and when to buy.

6. Primus Guaranty Ltd (PRS): Primus increased by 12.7% since September. Tom Brown’s Second Curve is also a large shareholder and insider of Primus Guaranty. During the past three months some insiders were selling below $5 per share whereas Tom Brown was adding to his holdings at or below $5.

7. Synovus Financial (SNV): There weren’t any significant insider transactions at Synovus since September 30th. Synovus gained 13% since September but not before dipping below $2 per share at the end of November. Currently the stock trades at $2.77.

8. Taylor Capital Group Inc (TAYC): The stock gained almost 10% since the end of September. Tom Brown is also a 10% large shareholder of Taylor Capital and has to report his transactions. He has been buying Taylor Capital consistently until the end of October. He stopped buying after a more than 20% increase in less than 3 months.

9. Western Alliance Bancorp (WAL): Western Alliance gained nearly 9% since September. Todd Marshall, a director of WAL, bought 134,000 shares between $5.98 and $6.21 per share at the end of November. As you may see, Todd Marshall’s return is twice as much as Thomas Brown’s.

10. Wintrust Financial Corp (WTFC): Wintrust Financial increased by a little more than 1% since September. We don’t have any recent insider transactions at Wintrust.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!